Dr. Funda Suer Joins Quadrant Biosciences as EVP of Clinical Diagnostics and CLIA Laboratory Director – QNT Press Release


Suer to expand molecular genetic testing portfolio at Quadrant

SYRACUSE, NY, May 31, 2022 /PRNewswire/ — Quadrant Biosciences Inc., a developer of novel molecular diagnostics, announced that Dr. Funda Suer has joined the company as Executive Vice President of Clinical Diagnostics and CLIA Laboratory Director. In this role, Funda will lead and support Laboratory Services in the development and adoption of new assays.

Dr. Suer joins Quadrant from Mount Sinai Genomics, Sem4, where she served most recently as Senior Director of Clinical Laboratory and Head of Diagnostic Testing. There she played a key role in the successful submission of many laboratory-developed diagnostic tests (LDT) to the New York State Department of Health (NYS DOH) and test launches. Dr. Suer has extensive experience …

Full story available on Benzinga.com



Source link

Recommended For You

About the Author: News Center